PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA.\', \'Institute for Immunity, Transplantation, and Infection, Stanford University, Stanford, CA, USA.\', \'Infectious Disease Initiative, Chan Zuckerberg Biohub, San Francisco, CA, USA.\', \'J. Craig Venter Institute, 4120 Capricorn Lane, La Jolla, CA 92037, USA; Department of Infectious Diseases, University of California San Diego, La Jolla, CA 92037, USA.\', \'Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA; Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA; Chan Zuckerberg Biohub, San Francisco, CA, USA. Electronic address: taiawang@stanford.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0169-409X(21)00024-710.1016/j.addr.2021.01.014
?:hasPublicationType
?:journal
  • Advanced drug delivery reviews
is ?:pmid of
?:pmid
?:pmid
  • 33482248
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.09
?:rankingScore_hIndex
  • 261
?:title
  • SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all